Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

alpha-1A Adrenergic R/ADRA1A Antibody (518508), PE/Cy5.5, Novus Biologicals™
SDP

Mouse Monoclonal Antibody

Supplier:  Novus Biologicals FAB10298PECY55

Catalog No. NB315242


Only null left
Add to Cart

Description

Description

alpha-1A Adrenergic R/ADRA1A Monoclonal antibody specifically detects alpha-1A Adrenergic R/ADRA1A in Human samples. It is validated for Flow Cytometry
Specifications

Specifications

alpha-1A Adrenergic R/ADRA1A
Monoclonal
PE-Cyanine5.5
PBS
Mouse
Protein A or G purified from hybridoma culture supernatant
RUO
Primary
Human
Purified
Flow Cytometry
518508
Flow Cytometry
ADRA1Cadrenergic, alpha-1A-, receptor variant 1, ADRA1L1, adrenergic, alpha -1A-, receptor, adrenergic, alpha-1A-, receptor, adrenergic, alpha-1A-, receptor variant 3, adrenergic, alpha-1A-, receptor variant 5, adrenergic, alpha-1A-, receptor variant 8, adrenergic, alpha-1C-, receptor, alpha-1A adrenergic receptor, Alpha-1A adrenoceptor, Alpha-1A adrenoreceptor, ALPHA1AAR, Alpha-1C adrenergic receptor, Alpha-adrenergic receptor 1c, G protein coupled receptor
HEK293 human embryonic kidney cell line transfected with human alpha-1 Adrenergic R/ADRA1A, Accession # P35348
0.1 mL
Apoptosis, GPCR, Neuroscience
148
Store at 4C in the dark. Do not freeze.
IgG1
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.